Riskpilot← Back to searchSign inGet full accessProMedical Oy
OYActiveY-tunnus 2086301-4Valimotie 1-BWholesale of pharmaceutical and medical goods · NACE 4646Est. 200720 employeeswww.promedical.fi
Revenue 2024
EUR 3,6M
-9% vs 2023
EBITDA margin
-13.1%
-536% vs 2023
Equity ratio
23.1%
Financial strength
Net profit 2024
EUR -597K
-3740% vs 2023
| Revenue | EUR 3,6M | -9% |
| EBITDA | EUR -475K | -536% |
| Net profit | EUR -597K | -3740% |
| Total assets | EUR 1,8M | -24% |
| Equity | EUR 417K | -62% |
| Employees | 20 | — |
Legal name
ProMedical Oy
Y-tunnus number
2086301-4
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9. tammikuuta 2007
Share capital
EUR 10 000
Employees
20 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on sairaala- ja terveydenhoitoalan tarvikkeiden ja laitteiden myynti ja huolto. Lisäksi yhtiö harjoittaa alaan liittyvää tutkimustoimintaa, konsultointia, järjestelmien ja laitteiden valmistusta ja kauppaa. Yhtiö voi omistaa arvopapereita, harjoittaa arvopaperikauppaa sekä yhtiön toimintaa tukevaa sijoitus- ja rahoitustoimintaa. Yhtiö voi harjoittaa toimialansa mukaista toimintaa sekä välittömästi itse että tytäryhtiöidensä ja yhteisyritystensä välityksellä. Yhtiön toimialana on lisäksi omistaa, hallita ja vuokrata, kiinteistöjä tai sellaisen hallintaan oikeuttavia osakkeita, lomaosakkeita sekä muita arvopapereita koti- ja ulkomailla.
Address
Valimotie 1-B
Phone
+3580103875700
Email
info@promedical.fi
Website
www.promedical.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 762 | 3 192 | 5 253 | 3 980 | 3 612 |
| Staff expenses | −695 | −760 | −1 038 | −1 022 | −1 338 |
| EBITDA | 223 | 369 | 743 | 109 | −475 |
| Depreciation & amort. | −82 | −74 | −116 | −79 | −105 |
| EBIT | 142 | 295 | 628 | 30 | −579 |
| Net financials | −7 | −8 | −22 | −5 | −22 |
| Profit before tax | 135 | 287 | 606 | 25 | −601 |
| Tax | 27 | 58 | 124 | 8 | −4 |
| Net profit | 107 | 229 | 482 | 16 | −597 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 579 | 1 588 | 2 675 | 2 392 | 1 806 |
| Equity | 1 005 | 757 | 1 179 | 1 101 | 417 |
| Long-term debt | 187 | 392 | 330 | 159 | 316 |
| Short-term debt | 387 | 440 | 1 167 | 1 131 | 1 073 |
| Total debt | 574 | 832 | 1 497 | 1 291 | 1 389 |
EBITDA margin
-13.1%
This company
15.8%
Market median
-183% vs market
20202024
Equity ratio
23.1%
This company
38.2%
Market median
-40% vs market
20202024
Return on equity
-143.3%
This company
18.4%
Market median
-879% vs market
20202024
Net profit margin
-16.5%
This company
8.1%
Market median
-304% vs market
20202024
Asset turnover
2.00×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
3.33×
This company
0.62×
Market median
-437% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-10-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (5) | ||
AM Deputy auditor | Deputy auditor | 2007 – 2020 |
AJ Deputy Member | Deputy Member | 2012 – 2020 |
AO Chief Executive Officer | Chief Executive Officer | 2007 – 2020 |
VL | Audit | 2020 – 2023 |
IT Audit | Audit | 2007 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairperson | 2021 | |
| Board of Directors | 2020 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Board of Directors | 2021 – 2026 | |
| Board of Directors | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ProMedical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ani Marja-Liisa Salakari | Deputy auditor | 0 companies |
| Joona Oskari Pulliainen | Chief Executive Officer | 0 companies |
| Antti Juha Riihelä | Deputy Member | 0 companies |
| Aki Olavi Pulliainen | Chief Executive Officer | 0 companies |
| Viivi Liisa Emilia Ahomäki | Audit | 0 companies |
| Ilkka Tapio Merimaa | Audit | 0 companies |
| William Matti Copeland | Chairperson | 0 companies |
| Peik Johannes Lehtonen | Board of Directors | 0 companies |
| Panu Samuel Lauha | Board of Directors | 0 companies |
| Pauli Ilmari Waroma | Board of Directors | 0 companies |
| Pauliina Marianna Bovellán | Board of Directors | 0 companies |
| Paulus Mikael Torkki | Board of Directors | 0 companies |